Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study

Gut bacterial microbiota is altered in patients with advanced renal disease and those on dialysis. However, it is not clear yet what bacterial composition changes are due to the renal insufficiency per se, and what are in result of the accompanying interventions and comorbid conditions. Most studies analyzed diabetic nephropathy, hypertensive nephropathy, and glomerulonephritis patients which might have directly influenced the microbiome regardless of alterations in renal function. We present in this report changes in gut bacterial microbiota in a highly selected group of patients with strict inclusion criteria to eliminate the effects of the confounding factors on the microbiome composition. We conducted multiple analysis approaches according to participants’ renal function to further understand microbiome alteration in different degrees of renal insufficiency. An interesting group of bacteria showed a step-wise change in relative abundance in response to the three groups’ analysis. These bacteria either decreased or increased from mild, moderate to severe renal insufficiency indicating strong and direct effects of the uremic milieu on its relative abundance. We also ran a sensitivity analysis that took into account an assembly of the significant taxa observed in an approach to investigate whether these taxa can fully explain the separation noted between the groups. We determined the projected metabolic pathways altered according to the gut microbiota composition changes. This report not only delineates with a higher certainty the effects of alteration in renal function on the microbiome, but also explores the possible role of dysbiosis on comorbid conditions through alterations in the projected metabolic pathways. Impact statement The heterogeneity of the renal disease, therapeutic interventions, and the original cause of the renal failure, all directly affect the microbiota. We delineate in this report the direct effect of decreased renal function on the bacterial composition following stringent criteria to eliminate the possibilities of other confounding factors and dissect the direct effects of the uremic milieu. We analyzed the microbiome following three different approaches to further evaluate the effects of mild, moderate and advanced renal insufficiency on the microbiome. We also present here a detailed functional analysis of the projected altered pathways secondary to changes in the microbiome composition.

[1]  R. Genco,et al.  Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis. , 2018, American journal of physiology. Renal physiology.

[2]  Guixia Wang,et al.  The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus , 2018, Journal of diabetes research.

[3]  Michael Y. Gerner,et al.  Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism , 2018, Nature.

[4]  M. Veldhoen,et al.  Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases , 2018, Nature Communications.

[5]  T. Nickolas,et al.  KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  Rabi Yacoub,et al.  Lupus: The microbiome angle. , 2017, Immunobiology.

[7]  Wei Zheng,et al.  Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial , 2017, PloS one.

[8]  Mary B Leonard,et al.  Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. , 2017, Kidney international.

[9]  Y. Fujioka,et al.  Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis? , 2017, Journal of atherosclerosis and thrombosis.

[10]  Hong-Wei Zhou,et al.  Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients , 2017, Scientific Reports.

[11]  J. Adamski,et al.  Metabolomics for clinical use and research in chronic kidney disease , 2017, Nature Reviews Nephrology.

[12]  G. Parati,et al.  The systemic nature of CKD , 2017, Nature Reviews Nephrology.

[13]  William Tottey,et al.  Colonic Transit Time Is a Driven Force of the Gut Microbiota Composition and Metabolism: In Vitro Evidence , 2017, Journal of neurogastroenterology and motility.

[14]  T. R. Licht,et al.  Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut , 2016, Nature Microbiology.

[15]  Vinícius Andrade-Oliveira,et al.  The microbiota and chronic kidney diseases: a double-edged sword , 2016, Clinical & translational immunology.

[16]  T. Preston,et al.  Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.

[17]  Judith Aron-Wisnewsky,et al.  The gut microbiome, diet, and links to cardiometabolic and chronic disorders , 2016, Nature Reviews Nephrology.

[18]  M. Kanehisa,et al.  BlastKOALA and GhostKOALA: KEGG Tools for Functional Characterization of Genome and Metagenome Sequences. , 2016, Journal of molecular biology.

[19]  R. Follador,et al.  Iron Modulates Butyrate Production by a Child Gut Microbiota In Vitro , 2015, mBio.

[20]  D. Fouque,et al.  Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet. , 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[21]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[22]  Jens Roat Kultima,et al.  Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2016 .

[23]  P. Jose,et al.  Gut microbiota in hypertension , 2015, Current opinion in nephrology and hypertension.

[24]  V. Jala,et al.  Evidence for a link between gut microbiota and hypertension in the Dahl rat. , 2015, Physiological genomics.

[25]  C. Pepine,et al.  Gut Dysbiosis Is Linked to Hypertension , 2015, Hypertension.

[26]  S. Peterson,et al.  Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota , 2015, Clinical and experimental immunology.

[27]  K. Maloy,et al.  Modulation of immune development and function by intestinal microbiota. , 2014, Trends in immunology.

[28]  S. Hazen,et al.  The contributory role of gut microbiota in cardiovascular disease. , 2014, The Journal of clinical investigation.

[29]  Estela Trebicka,et al.  Intestinal Inflammation Modulates Expression of the Iron-Regulating Hormone Hepcidin Depending on Erythropoietic Activity and the Commensal Microbiota , 2014, The Journal of Immunology.

[30]  L. Gesualdo,et al.  What Would You Like to Eat, Mr CKD Microbiota? A Mediterranean Diet, please! , 2014, Kidney and Blood Pressure Research.

[31]  H. Tilg,et al.  Microbiota and diabetes: an evolving relationship , 2014, Gut.

[32]  Maurice Kriegel,et al.  Diet, microbiota and autoimmune diseases , 2014, Lupus.

[33]  Y. Belkaid,et al.  Role of the Microbiota in Immunity and Inflammation , 2014, Cell.

[34]  S. Rampelli,et al.  Inflammation and colorectal cancer, when microbiota-host mutualism breaks. , 2014, World journal of gastroenterology.

[35]  Jiajie Zhang,et al.  PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..

[36]  Jesse R. Zaneveld,et al.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.

[37]  S. Hazen,et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.

[38]  F. Bushman,et al.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.

[39]  G. Andersen,et al.  Chronic kidney disease alters intestinal microbial flora. , 2013, Kidney international.

[40]  Keith C. Norris,et al.  Role of Urea in Intestinal Barrier Dysfunction and Disruption of Epithelial Tight Junction in Chronic Kidney Disease , 2012, American Journal of Nephrology.

[41]  Michael A Kennedy,et al.  Quantification and statistical significance analysis of group separation in NMR-based metabonomics studies. , 2011, Chemometrics and intelligent laboratory systems : an international journal sponsored by the Chemometrics Society.

[42]  G. Macfarlane,et al.  Fermentation in the Human Large Intestine: Its Physiologic Consequences and the Potential Contribution of Prebiotics , 2011, Journal of clinical gastroenterology.

[43]  Jacques Amar,et al.  Gut microbiota and diabetes: from pathogenesis to therapeutic perspective , 2011, Acta Diabetologica.

[44]  Gaël Varoquaux,et al.  The NumPy Array: A Structure for Efficient Numerical Computation , 2011, Computing in Science & Engineering.

[45]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[46]  K. Verbeke,et al.  p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[47]  R. Pincus,et al.  Aitchison, J.: The Statistical Analysis of Compositional Data. Chapman and Hall, London ‐ New York 1986, XII, 416 pp., £ 25,00 , 2007 .

[48]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[49]  K. Verbeke,et al.  Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. , 2006, Kidney international.

[50]  Eoin L. Brodie,et al.  Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.

[51]  J. Bailey Metabolic acidosis: an unrecognized cause of morbidity in the patient with chronic kidney disease. , 2005, Kidney international. Supplement.

[52]  K. Kalantar-Zadeh,et al.  Risks of chronic metabolic acidosis in patients with chronic kidney disease. , 2005, Kidney international. Supplement.

[53]  J. Kraut,et al.  Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  Xiaonan H. Wang,et al.  Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis. , 2004, American journal of physiology. Renal physiology.

[55]  Chi-Sen Chang,et al.  Colonic transit time in long-term dialysis patients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[56]  M. Fine,et al.  Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index. , 2004, Journal of pain and symptom management.

[57]  K. Verbeke,et al.  Evidence for impaired assimilation of protein in chronic renal failure. , 2003, Kidney international.

[58]  H. Takanaga,et al.  Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. , 2002, Kidney international.

[59]  P. Toutain,et al.  Small bowel motility and colonic transit are altered in dogs with moderate renal failure. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[60]  F. Santos,et al.  Resistance to growth hormone and insulin-like growth factor-I in acidotic rats , 2000, Pediatric Nephrology.

[61]  R. Vanholder,et al.  p-cresol and uric acid: two old uremic toxins revisited. , 1997, Kidney international. Supplement.

[62]  E. Quintero,et al.  Gastrin mediates the increase in gastric cell growth in uremic rats. , 1995, The American journal of physiology.

[63]  N. Vaziri,et al.  Enhanced enteric excretion of urate in rats with chronic renal failure. , 1994, Clinical science.

[64]  R. Vanholder,et al.  Uremic toxicity: the middle molecule hypothesis revisited. , 1994, Seminars in nephrology.

[65]  J. Y. Kang,et al.  The gastrointestinal tract in uremia , 1993, Digestive diseases and sciences.

[66]  R. De Giorgio,et al.  Uremia increases gastric mucosal permeability and acid back-diffusion injury in the rat. , 1992, Gastroenterology.

[67]  J. Cummings,et al.  Effect of changing transit time on colonic microbial metabolism in man. , 1987, Gut.

[68]  John Aitchison,et al.  The Statistical Analysis of Compositional Data , 1986 .

[69]  R. Miller,et al.  Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. , 1985, The American journal of gastroenterology.

[70]  J. Cummings,et al.  The effect of meat protein and dietary fiber on colonic function and metabolism. I. Changes in bowel habit, bile acid excretion, and calcium absorption. , 1979, The American journal of clinical nutrition.

[71]  B. Widmer,et al.  Serum electrolyte and acid base composition. The influence of graded degrees of chronic renal failure. , 1979, Archives of internal medicine.

[72]  J. Cummings,et al.  The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. , 1979, The American journal of clinical nutrition.

[73]  Y. Sanz,et al.  Microbiota, inflammation and obesity. , 2014, Advances in experimental medicine and biology.

[74]  Jens Roat Kultima,et al.  Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2015, Nature.

[75]  Wes McKinney,et al.  Data Structures for Statistical Computing in Python , 2010, SciPy.

[76]  Matthew Novak,et al.  Improvement in Pittsburgh Symptom Score index after initiation of peritoneal dialysis. , 2008, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[77]  J. Bernardini,et al.  The relationship between symptoms, depression, and quality of life in peritoneal dialysis patients. , 2006, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[78]  Eric Jones,et al.  SciPy: Open Source Scientific Tools for Python , 2001 .

[79]  Fred L. Drake,et al.  The Python Language Reference Manual , 1999 .

[80]  P. Kes Serum gastrin concentration in chronic renal failure. , 1992, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[81]  D. Warnock Uremic acidosis. , 1988, Kidney international.

[82]  S. Shen,et al.  The statistical analysis of compositional data , 1983 .

[83]  Y. Lee,et al.  Urea concentration in intestinal fluids in normal and uremic dogs , 1971, Journal of surgical oncology.